Emma Holian

National University of Ireland — Ireland

Biochemistry, Genetics and Molecular Biology · Life Sciences

13h-index403citations27works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(11), Circular RNAs in diseases(9), Cancer-related molecular mechanisms research(8), Cancer Genomics and Diagnostics(5), Gene expression and cancer classification(4)

Publications27 total

Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial
Journal of the American College of Surgeons·2022· 16 citedOpen Access
GNOSIS: an R Shiny app supporting cancer genomics survival analysis with cBioPortal
HRB Open Research·2022· 2 citedOpen Access
Identification of a Five-MiRNA Expression Assay to Aid Colorectal Cancer Diagnosis
Gastrointestinal Disorders·2022· 2 citedOpen Access
Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer
Annals of Surgery·2022· 25 citedOpen Access
AB068. SOH22ABS116. Identification and investigation of a novel four miRNA expression assay to aid colorectal cancer diagnosis
Mesentery and Peritoneum·2022Open Access
MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer
Cancers·2022· 16 citedOpen Access
GNOSIS: an R Shiny app supporting cancer genomics survival analysis with cBioPortal
HRB Open Research·2022· 25 citedOpen Access
Data associated with "Survival outcomes are associated with genomic instability in luminal breast cancers".
Zenodo (CERN European Organization for Nuclear Research)·2021· 1 citedOpen Access
Data associated with "Survival outcomes are associated with genomic instability in luminal breast cancers".
Zenodo (CERN European Organization for Nuclear Research)·2021· 1 citedOpen Access
MicroRNAs as biomarkers of multimodal treatment for rectal cancer
British journal of surgery·2021· 7 citedOpen Access
Survival outcomes are associated with genomic instability in luminal breast cancers
PLoS ONE·2021· 11 citedOpen Access
Assessment of groundwater processes using censored data analysis incorporating non-detect chemical, physical, and biological data
Journal of Contaminant Hydrology·2020· 14 citedOpen Access
Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
Cancers·2020· 42 citedOpen Access
Investigating the Potential and Pitfalls of EV-Encapsulated MicroRNAs as Circulating Biomarkers of Breast Cancer
Cells·2020· 31 citedOpen Access
Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer
BMC Cancer·2019· 35 citedOpen Access
Quantifying Tip60 (Kat5) stratifies breast cancer
Scientific Reports·2019· 35 citedOpen Access
Relative and Absolute Expression Analysis of MicroRNAs Associated with Luminal A Breast Cancer– A Comparison
Pathology & Oncology Research·2019· 32 cited
Arsenic in Groundwater in South West Ireland: Occurrence, Controls, and Hydrochemistry
Frontiers in Environmental Science·2018· 14 citedOpen Access
Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab
Breast Cancer Research and Treatment·2017· 8 citedOpen Access
Screening of exosomal microRNAs from colorectal cancer cells
Cancer Biomarkers·2016· 42 cited
page 1 of 2Next →

Frequent Co-authors

Michael J. Kerin(15), Aoïfe Lowery(8), Nicola Miller(7), Róisín M. Dwyer(6), James A. L. Brown(6), Andrew McGuire(5), Ronan Waldron(5), O. Kalinina(5), Lydia King(5), Andrew Flaus(5), Aaron Golden(5), Máire‐Caitlín Casey(4), John Newell(4), Matthew G. Davey(4), Maxwell Paganga(4), Helen Heneghan(3), Ailbhe M. McDermott(3), Maccon Keane(3), Claire L. Glynn(3), Peter Dockery(3)